27655319|t|Establishment and application of a flow cytometry -based method for detecting histone acetylation levels
27655319|a|Histone deacetylase inhibitors, which have also received attention in AIDS and other diseases, are a new class of anticancer drugs developed in recent years. However, there is still a lack of a unified and reliable method for detecting histone acetylation levels in basic and clinical research. In this study, we developed a flow cytometry -based method to detect histone acetylation levels by comparing different sample processing temperature (on ice vs. room temperature), permeabilization method (intracellular vs. nuclear), antibody dose (antibody titration) and antibody incubation time (time gradient) using whole blood and peripheral blood mononuclear cells. In addition, we applied this optimized method in in vitro experiment and clinical trial of Chidamide (the only China FDA approved HDACi), the result of which confirmed that the flow cytometry -based method for detecting histone acetylation levels is a reliable, fast and convenient method which can be used in basic and clinical research.
27655319	35	49	flow cytometry	T059	C0016263
27655319	57	63	method	T170	C0025663
27655319	68	77	detecting	T033	C0442726
27655319	78	97	histone acetylation	T044	C1156200
27655319	98	104	levels	T080	C0441889
27655319	105	135	Histone deacetylase inhibitors	T116,T121,T126	C1512474
27655319	175	179	AIDS	T047	C0001175
27655319	190	198	diseases	T047	C0012634
27655319	219	235	anticancer drugs	T109,T121	C0003392
27655319	289	293	lack	T080	C0332268
27655319	299	306	unified	T080	C1706076
27655319	311	319	reliable	T170	C3858758
27655319	320	326	method	T170	C0025663
27655319	331	340	detecting	T033	C0442726
27655319	341	360	histone acetylation	T044	C1156200
27655319	361	367	levels	T080	C0441889
27655319	371	376	basic	T062	C0681833
27655319	381	398	clinical research	T062	C0008972
27655319	408	413	study	T062	C2603343
27655319	430	444	flow cytometry	T059	C0016263
27655319	452	458	method	T170	C0025663
27655319	462	468	detect	T061	C1511790
27655319	462	468	detect	T033	C0442726
27655319	469	488	histone acetylation	T044	C1156200
27655319	489	495	levels	T080	C0441889
27655319	499	508	comparing	T052	C1707455
27655319	519	525	sample	T167	C0370003
27655319	526	536	processing	T052	C1709694
27655319	537	548	temperature	T081	C0039476
27655319	553	556	ice	T197	C0020746
27655319	561	577	room temperature	T033	C1822393
27655319	561	577	room temperature	T033	C1822393
27655319	580	596	permeabilization	T043	C0007605
27655319	597	603	method	T170	C0025663
27655319	605	618	intracellular	T026	C0021868
27655319	623	630	nuclear	T026	C0028584
27655319	633	641	antibody	T116,T129	C0003241
27655319	642	646	dose	T081	C0178602
27655319	648	666	antibody titration	T059	C0522986
27655319	672	680	antibody	T116,T129	C0003241
27655319	681	696	incubation time	T079	C0040223
27655319	698	711	time gradient	T081	C0812409
27655319	719	730	whole blood	T031	C0370231
27655319	735	769	peripheral blood mononuclear cells	T025	C1321301
27655319	800	809	optimized	T052	C2698650
27655319	810	816	method	T170	C0025663
27655319	820	828	in vitro	T080	C1533691
27655319	829	839	experiment	T062	C0681814
27655319	844	858	clinical trial	T062	C0008976
27655319	862	871	Chidamide	T109,T121	C2932486
27655319	882	887	China	T083	C0008115
27655319	888	906	FDA approved HDACi	T170	C2700205
27655319	913	919	result	T169	C1274040
27655319	929	938	confirmed	T033	C0750484
27655319	948	962	flow cytometry	T059	C0016263
27655319	970	976	method	T170	C0025663
27655319	981	990	detecting	T033	C0442726
27655319	991	1010	histone acetylation	T044	C1156200
27655319	1011	1017	levels	T080	C0441889
27655319	1023	1031	reliable	T170	C3858758
27655319	1033	1037	fast	T080	C0456962
27655319	1042	1052	convenient	T080	C3831015
27655319	1053	1059	method	T170	C0025663
27655319	1081	1086	basic	T062	C0681833
27655319	1091	1108	clinical research	T062	C0008972